Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis
Artesunate, the recommended drug for severe malaria, rapidly clears the malaria parasite from infected patients but frequently induces anemia-called post-artesunate delayed hemolysis (PADH)-for which a simple predictive test is urgently needed. The underlying event in PADH is the expulsion of artesu...
Príomhchruthaitheoirí: | Ndour, P, Larréché, S, Mouri, O, Argy, N, Gay, F, Roussel, C, Jauréguiberry, S, Perillaud, C, Langui, D, Biligui, S, Chartrel, N, Mérens, A, Kendjo, E, Ghose, A, Hassan, M, Hossain, M, Kingston, H, Plewes, K, Dondorp, A, Danis, M, Houzé, S, Bonnefoy, S, Thellier, M, Woodrow, C, Buffet, P, French Artesunate Working Group |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
American Association for the Advancement of Science
2017
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
de réir: Rueangweerayut, R, et al.
Foilsithe / Cruthaithe: (2012) -
Population pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patients.
de réir: Simpson, J, et al.
Foilsithe / Cruthaithe: (2006) -
Fake artesunate in southeast Asia.
de réir: Newton, P, et al.
Foilsithe / Cruthaithe: (2001) -
Fake artesunate in southeast Asia
de réir: Newton, P, et al.
Foilsithe / Cruthaithe: (2001) -
Counterfeit artesunate antimalarials in southeast Asia.
de réir: Newton, P, et al.
Foilsithe / Cruthaithe: (2003)